動物用添加剤市場- 世界の産業規模、シェア、動向、機会、予測、用途別、化学グループ別、動物タイプ別、最終用途別、地域別、競合別、2019年～2029年

動物用添加剤の世界市場規模は2023年に12億7,000万米ドルとなり、2029年までのCAGRは4.36%で、予測期間中に着実な成長が予測されています。

動物用医薬品の有効性、安全性、安定性を確保する上で、医薬品製剤の担体や安定剤として使用される不活性物質である賦形剤は重要な役割を果たしています。この市場には、充填剤、結合剤、崩壊剤、滑沢剤、香料など、動物用医薬品向けに特別に設計された多様な賦形剤が含まれます。この市場は、コンパニオンアニマルに対する需要の増加、動物疾病の蔓延の増加、動物の健康と福祉に関する意識の高まりなど、いくつかの要因によって牽引されています。

さらに、製薬技術と製剤化技術の進歩により、動物用医薬品に使用できる賦形剤のレパートリーが拡大し、さまざまな動物種特有の生理学的特性に合わせた新規剤形や強化型ドラッグデリバリーシステムの開発が促進されています。地域的には、この市場は世界の広がりを見せており、北米と欧州ではペットの飼育率が高く、動物用医薬品に関する規制基準が厳しいことから、市場が確立しています。しかし、アジア太平洋とラテンアメリカの新興国は、急速な都市化、可処分所得の増加、家畜生産と畜産業の重視の高まりに後押しされて、大きな成長を遂げるものと思われます。市場の主なプレーヤーは、嗜好性、生物学的利用能、安定性といった動物用医薬品の製剤化に関連する特定の課題に対処する革新的な賦形剤を導入するための研究開発に積極的に取り組んでいます。

さらに、戦略的提携、合併、買収は、市場参入企業が製品ポートフォリオを拡大し、市場での存在感を高め、新たな機会を活用するために採用する一般的な戦略です。動物用医薬品に適用される安全性と有効性の基準は厳しいため、規制遵守と品質保証は依然としてメーカーにとって最重要事項です。今後の展望として、研究開発への継続的な投資、ペットの飼育率の増加、多様な動物の健康問題に対応するための特殊な動物用医薬品に対する需要の高まりなどを背景に、動物用添加剤市場は持続的な成長が見込まれています。しかし、規制の複雑さ、価格圧力、進化する疾病情勢に対処するための革新的なソリューションの必要性などの課題により、このダイナミックな市場情勢において将来の成長見通しを引き出し、競争優位性を維持するためには、業界全体で革新と協調を継続する必要があります。

市場促進要因

ペット飼育率の増加

動物疾病の有病率の上昇

製剤技術の進歩

主な市場課題

規制遵守と品質保証

価格圧力とコスト制約

主な市場動向

ペット医薬品産業の拡大

ドラッグデリバリーシステムの技術進歩

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の動物用添加剤市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 用途別（生物製剤、医薬品、医薬用飼料添加物）
  • 化学グループ別（ポリマー、アルコール、脂質、無機塩、その他）
  • 動物タイプ別（生産動物、ペット動物）
  • 最終用途別（可溶化剤/溶剤、結合剤、安定剤、コーティング剤、希釈剤および充填剤、その他）
  • 地域別
  • 企業別（2023年）
• 市場マップ

第6章 アジア太平洋の動物用添加剤市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 用途別
  • 化学グループ別
  • 動物の種類別
  • 最終用途別
  • 国別
• アジア太平洋：国別分析
  • 中国
  • インド
  • オーストラリア
  • 日本
  • 韓国

第7章 欧州の動物用添加剤市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 用途別
  • 化学グループ別
  • 動物の種類別
  • 最終用途別
  • 国別
• 欧州：国別分析
  • フランス
  • ドイツ
  • スペイン
  • イタリア
  • 英国

第8章 北米の動物用添加剤市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 用途別
  • 化学グループ別
  • 動物の種類別
  • 最終用途別
  • 国別
• 北米：国別分析
  • 米国
  • メキシコ
  • カナダ

第9章 南米の動物用添加剤市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 用途別
  • 化学グループ別
  • 動物の種類別
  • 最終用途別
  • 国別
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの動物用添加剤市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 用途別
  • 化学グループ別
  • 動物の種類別
  • 最終用途別
  • 国別
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • エジプト

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の動向
• 製品の発売（ある場合）
• 合併および買収（ある場合）

第13章 世界の動物用添加剤市場：SWOT分析

第14章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第15章 競合情勢

• Croda International Plc
• JRS PHARMA GmbH & Co. KG
• Colorcon
• Quality Chemicals S.L.
• IOI Oleo GmbH
• Lipoid GmbH
• Gattefosse SAS
• Azelis Group
• Ashland Global Holdings Inc.
• Spectrum Chemical Mfg. Corp

第16章 戦略的提言

第17章 調査会社について・免責事項

Global Veterinary Excipients Market was valued at USD 1.27 Billion in 2023 and is anticipated to project steady growth in the forecast period with a CAGR of 4.36% through 2029. Excipients, inert substances used as carriers or stabilizers in pharmaceutical preparations, play a critical role in ensuring the efficacy, safety, and stability of veterinary drugs. This market encompasses a diverse array of excipients, including fillers, binders, disintegrants, lubricants, and flavoring agents, among others, specifically designed for veterinary applications. The market is driven by several factors, including the increasing demand for companion animals, the rising prevalence of animal diseases, and the growing awareness regarding animal health and welfare.

Additionally, advancements in pharmaceutical technology and formulation techniques are expanding the repertoire of excipients available to veterinary medicine, facilitating the development of novel dosage forms and enhanced drug delivery systems tailored to the unique physiological characteristics of various animal species. Geographically, the market exhibits a global footprint, with established markets in North America and Europe, driven by robust pet ownership rates and stringent regulatory standards governing veterinary pharmaceuticals. However, emerging economies in Asia-Pacific and Latin America are poised to witness significant growth, fueled by rapid urbanization, increasing disposable incomes, and a growing emphasis on livestock production and animal husbandry. Key market players are actively engaged in research and development initiatives to introduce innovative excipients that address specific challenges associated with veterinary drug formulation, such as palatability, bioavailability, and stability.

Moreover, strategic collaborations, mergers, and acquisitions are commonplace strategies employed by industry participants to expand their product portfolios, enhance market presence, and capitalize on emerging opportunities. Regulatory compliance and quality assurance remain paramount considerations for manufacturers, given the stringent safety and efficacy standards governing veterinary pharmaceuticals. Looking ahead, the Veterinary Excipients Market is poised for sustained growth, driven by ongoing investments in research and development, increasing pet ownership rates, and the rising demand for specialized veterinary medicines tailored to address a diverse range of animal health concerns. However, challenges such as regulatory complexities, pricing pressures, and the need for innovative solutions to address evolving disease landscapes will necessitate continued innovation and collaboration across the industry to unlock future growth prospects and sustain competitive advantage in this dynamic market landscape.

Key Market Drivers

Increasing Pet Ownership Rates

Increasing pet ownership rates are playing a pivotal role in boosting the Veterinary Excipients Market, driving demand for pharmaceutical products tailored to the unique health needs of companion animals. Across the globe, there has been a notable surge in the number of households welcoming pets into their homes, ranging from dogs and cats to birds, reptiles, and small mammals. This trend is particularly pronounced in developed regions such as North America, Europe, and parts of Asia-Pacific, where pet ownership has become increasingly prevalent as a result of changing lifestyles, cultural attitudes, and socio-economic factors.

As pet owners prioritize the health and well-being of their animal companions, the demand for veterinary pharmaceuticals has experienced a corresponding increase. Veterinary excipients, inert substances used as carriers or stabilizers in pharmaceutical preparations, play a crucial role in ensuring the efficacy, safety, and palatability of medications administered to pets. Excipients are essential components of various dosage forms, including tablets, capsules, liquids, and topical formulations, facilitating drug delivery and enhancing patient compliance.

The growing pet humanization trend, wherein pets are increasingly viewed as members of the family, has further fueled the demand for high-quality veterinary pharmaceuticals formulated with advanced excipients. Pet owners are willing to invest in premium healthcare products and services to ensure the health and longevity of their beloved companions, driving innovation and expansion within the Veterinary Excipients Market. Manufacturers are responding to this trend by developing specialized excipients tailored to the unique physiological characteristics of different animal species, as well as addressing specific challenges such as palatability, ease of administration, and stability.

Moreover, the increasing prevalence of pet insurance and the availability of advanced veterinary care options have contributed to the rising demand for pharmaceutical products in the pet healthcare sector. As veterinary practices adopt more sophisticated treatment modalities and diagnostic technologies, the need for high-quality medications formulated with advanced excipients becomes even more pronounced. Excipients play a critical role in supporting the development of innovative drug delivery systems and dosage forms that meet the evolving needs of veterinary practitioners and pet owners alike.

Rising Prevalence of Animal Diseases

The rising prevalence of animal diseases is a significant driver behind the growth of the Veterinary Excipients Market, as it fuels the demand for effective pharmaceutical solutions to combat various health issues affecting animals. Across the globe, the intensification of livestock production, changes in farming practices, and increasing urbanization have contributed to the spread of infectious diseases among animals. Additionally, the emergence of novel pathogens and zoonotic diseases further exacerbates the need for robust veterinary pharmaceuticals, thereby driving the market for excipients.

Excipients, inert substances used as carriers or stabilizers in pharmaceutical preparations, play a crucial role in formulating veterinary drugs that effectively treat and prevent a wide range of animal diseases. From antimicrobials and vaccines to parasiticides and analgesics, excipients are essential components of various dosage forms, including oral tablets, injectables, and topical formulations. These excipients help enhance the stability, bioavailability, and palatability of active pharmaceutical ingredients, ensuring optimal efficacy and safety in treating animal diseases.

Moreover, the rising prevalence of animal diseases not only affects livestock production but also impacts companion animals, wildlife, and aquatic species, driving demand for veterinary pharmaceuticals across diverse sectors. Excipients enable the development of innovative drug delivery systems and dosage forms that cater to the unique physiological characteristics of different animal species, thereby expanding the market for veterinary excipients.

As governments and regulatory agencies implement measures to control the spread of animal diseases and safeguard public health, there is a growing emphasis on the development and use of veterinary pharmaceuticals formulated with advanced excipients. Manufacturers are investing in research and development initiatives to introduce new excipients that address specific challenges associated with veterinary drug formulation, such as bioavailability, stability, and ease of administration. Additionally, strategic collaborations and partnerships between industry stakeholders are facilitating the exchange of knowledge and expertise to accelerate innovation in the Veterinary Excipients Market.

Technological Advancements in Pharmaceutical Formulation

Technological advancements in pharmaceutical formulation are instrumental in propelling the growth of the Veterinary Excipients Market, revolutionizing the development of veterinary pharmaceuticals and expanding the scope of excipient utilization. These advancements encompass a wide range of innovations, including novel drug delivery systems, advanced manufacturing techniques, and cutting-edge formulation technologies, all of which contribute to the optimization of veterinary drug efficacy, safety, and stability.

One key area of technological advancement driving the Veterinary Excipients Market is the development of innovative drug delivery systems tailored to the unique physiological characteristics of animals. Controlled-release formulations, for example, enable sustained drug release over an extended period, reducing the frequency of dosing and improving patient compliance. Nanoparticle-based delivery systems offer targeted drug delivery to specific tissues or organs, enhancing therapeutic efficacy while minimizing adverse effects. Excipients play a critical role in optimizing the performance and stability of these advanced drug delivery systems, ensuring precise dosing and consistent drug release profiles.

Additionally, advancements in manufacturing techniques such as hot-melt extrusion, spray drying, and microencapsulation have expanded the repertoire of excipients available for veterinary pharmaceutical formulations. These techniques enable the incorporation of poorly soluble drugs into solid dosage forms, enhancing their bioavailability and therapeutic efficacy. Excipients act as carriers or stabilizers in these formulations, facilitating drug dispersion and preventing degradation during manufacturing and storage.

Also, technological innovations in formulation technologies have led to the development of multifunctional excipients that offer enhanced performance and versatility in veterinary drug formulations. Excipients with muco-adhesive properties, for example, improve drug retention and absorption at mucosal surfaces, making them ideal for oral, buccal, and nasal drug delivery routes. Excipients with taste-masking capabilities improve palatability and acceptance of oral dosage forms, particularly in companion animals.

Key Market Challenges

Regulatory Compliance and Quality Assurance

One of the primary challenges facing the Veterinary Excipients Market is regulatory compliance and quality assurance. Veterinary pharmaceuticals are subject to stringent regulatory standards governing their formulation, manufacturing, and distribution. Excipients used in these products must comply with regulatory requirements set forth by government agencies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA). Ensuring compliance with these regulations can be time-consuming and costly for manufacturers, particularly small and medium-sized enterprises (SMEs) with limited resources. Moreover, maintaining quality assurance throughout the supply chain is essential to prevent contamination, adulteration, or other quality issues that could compromise the safety and efficacy of veterinary drugs.

Pricing Pressures and Cost Constraints

Pricing pressures and cost constraints pose significant challenges to participants in the Veterinary Excipients Market. As competition intensifies and market dynamics evolve, manufacturers face downward pressure on prices, particularly for generic excipients with commoditized properties. This can erode profit margins and hinder investment in research and development initiatives aimed at introducing innovative excipients with enhanced functionality or performance. Additionally, cost constraints may limit the ability of manufacturers to adopt advanced manufacturing technologies or implement quality control measures, further exacerbating challenges related to regulatory compliance and product quality.

Key Market Trends

Expansion of the Pet Pharmaceutical Industry

The expansion of the pet pharmaceutical industry is playing a significant role in boosting the Global Veterinary Excipients Market, driving demand for excipients used in the formulation of medications tailored to the health needs of companion animals. As pet ownership rates continue to rise worldwide and pet owners increasingly prioritize the health and well-being of their animal companions, the demand for veterinary pharmaceuticals has experienced a corresponding increase. This trend is particularly pronounced in developed regions such as North America, Europe, and parts of Asia-Pacific, where pet ownership is widespread and pet care spending is on the rise.

The expanding pet pharmaceutical industry encompasses a wide range of products, including medications for the treatment and prevention of various health conditions affecting companion animals. Excipients, inert substances used as carriers or stabilizers in pharmaceutical preparations, play a crucial role in ensuring the efficacy, safety, and palatability of these medications. Excipients are essential components of various dosage forms, including tablets, capsules, liquids, and topical formulations, facilitating drug delivery and enhancing patient compliance.

As the pet pharmaceutical industry continues to grow, so too does the demand for excipients formulated with advanced technologies and tailored to the unique physiological characteristics of different animal species. Manufacturers are investing in research and development initiatives to introduce new excipients that address specific challenges associated with veterinary drug formulation, such as bioavailability, stability, and palatability. Additionally, strategic collaborations and partnerships between industry stakeholders are driving innovation and facilitating the development of novel drug delivery systems optimized for companion animals.

The expansion of the pet pharmaceutical industry is also fueling investments in manufacturing infrastructure and production capacity, further stimulating growth in the Veterinary Excipients Market. As manufacturers scale up their operations to meet the growing demand for veterinary pharmaceuticals, the need for high-quality excipients that meet regulatory requirements and ensure product safety and efficacy becomes increasingly critical. Moreover, the expanding pet pharmaceutical industry presents opportunities for excipient manufacturers to diversify their product portfolios and expand their market presence. By developing excipients specifically designed for veterinary applications, manufacturers can tap into a lucrative and rapidly growing market segment while leveraging their expertise and capabilities in pharmaceutical formulation and manufacturing.

Technological Advancements in Drug Delivery Systems

Technological advancements in drug delivery systems are significantly boosting the global Veterinary Excipients Market, revolutionizing the formulation and administration of veterinary pharmaceuticals. These advancements encompass a wide range of innovative approaches aimed at improving drug targeting, bioavailability, and patient compliance in animals. As the demand for more effective and convenient treatment options for companion and production animals continues to rise, the role of excipients in facilitating these advancements becomes increasingly critical.

One of the key areas of technological advancement in drug delivery systems is the development of controlled-release formulations for veterinary pharmaceuticals. These formulations allow for sustained drug release over an extended period, reducing the frequency of dosing and improving patient compliance. Excipients play a crucial role in optimizing the release kinetics and stability of these formulations, ensuring consistent drug levels in the bloodstream and maximizing therapeutic efficacy.

Nanoparticle-based drug delivery systems are another innovative approach that is gaining traction in the veterinary pharmaceutical industry. These systems enable targeted drug delivery to specific tissues or organs, enhancing therapeutic outcomes while minimizing systemic side effects. Excipients serve as carriers or stabilizers for nanoparticles, facilitating their dispersion and preventing aggregation during formulation and storage. By leveraging the unique properties of excipients, manufacturers can develop nanoparticle formulations that offer improved drug solubility, bioavailability, and tissue penetration in animals.

In addition to controlled-release and nanoparticle-based delivery systems, other technological advancements such as micro-particles, liposomes, and hydrogels are also contributing to the growth of the Veterinary Excipients Market. These systems offer diverse options for formulating veterinary pharmaceuticals with enhanced performance and versatility, addressing specific challenges associated with drug delivery in animals.

Segmental Insights

Chemical Group Insights

Based on the chemical group, polymers segment emerged as the dominant segment in the global veterinary excipients market in 2023. This is primarily due to several inherent properties and versatile applications of polymers in veterinary pharmaceutical formulations. Polymers offer a wide range of functionalities that make them ideal excipients for veterinary drug delivery systems. One key advantage of polymers is their ability to serve as inert carriers or binders in solid dosage forms such as tablets and capsules. Polymers can improve the mechanical properties of these formulations, enhancing their durability and stability during manufacturing, storage, and administration. Additionally, polymers can act as sustained-release agents, controlling the release of active pharmaceutical ingredients over an extended period, thereby improving patient compliance and therapeutic efficacy.

Animal Type Insights

Based on the animal type, production animals segment emerged as the dominant segment in the global veterinary excipients market in 2023. The intensification of livestock production and the increasing prevalence of infectious diseases among production animals have heightened the demand for veterinary pharmaceuticals formulated with advanced excipients. Excipients enhance the stability, bioavailability, and efficacy of active pharmaceutical ingredients in these medications, thereby supporting disease prevention, management, and treatment in production animal populations. Additionally, advancements in animal nutrition and welfare practices have led to the development of specialty feed additives and nutritional supplements for production animals.

Regional Insights

North America emerged as the dominant player in the global veterinary excipients market in 2023, holding the largest market share. North America boasts a sizable and rapidly growing pet population, with a significant portion of households owning one or more companion animals. This high pet ownership rate translates into robust demand for veterinary pharmaceuticals, including medications formulated with excipients. As pet owners prioritize the health and well-being of their animals, they are willing to invest in premium healthcare products and services, further driving the market for veterinary excipients in the region.

Key Market Players

Croda International plc

JRS PHARMA GmbH + Co. KG

Colorcon

Quality Chemicals S.L

IOI Oleo GmbH

Lipoid GmbH

Gattefosse SAS

Azelis Group

Ashland Global Holdings Inc.

Spectrum Chemical Mfg. Corp.

Report Scope:

In this report, the Global Veterinary Excipients Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Veterinary Excipients Market, By Application:

Biologics Pharmaceuticals Medicated Feed Additives

Veterinary Excipients Market, By Chemical Group:

Polymers Alcohols Lipids Mineral Salts Others

Veterinary Excipients Market, By Animal Type:

Production Animals Companion Animals

Veterinary Excipients Market, By End Use:

Solubilizers/ Solvents Binders Stabilizers Coating Diluents & fillers Others

Veterinary Excipients Market, By Region:

North America
• United States
• Canada
• Mexico
Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
Asia-Pacific
• China
• India
• Japan
• Australia
• South Korea
South America
• Brazil
• Argentina
• Colombia
Middle East & Africa
• South Africa
• Saudi Arabia
• UAE
• Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Veterinary Excipients Market.

Available Customizations:

Global Veterinary Excipients Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Veterinary Excipients Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Application (Biologics, Pharmaceuticals, Medicated Feed Additives)
  • 5.2.2. By Chemical Group (Polymers, Alcohols, Lipids, Mineral Salts, Others)
  • 5.2.3. By Animal Type (Production Animals, Companion Animals)
  • 5.2.4. By End Use (Solubilizers/ Solvents, Binders, Stabilizers, Coating, Diluents & fillers, Others)
  • 5.2.5. By Region
  • 5.2.6. By Company (2023)
• 5.3. Market Map

6. Asia Pacific Veterinary Excipients Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Application
  • 6.2.2. By Chemical Group
  • 6.2.3. By Animal Type
  • 6.2.4. By End Use
  • 6.2.5. By Country
• 6.3. Asia Pacific: Country Analysis
  • 6.3.1. China Veterinary Excipients Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Application
      • 6.3.1.2.2. By Chemical Group
      • 6.3.1.2.3. By Animal Type
      • 6.3.1.2.4. By End Use
  • 6.3.2. India Veterinary Excipients Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Application
      • 6.3.2.2.2. By Chemical Group
      • 6.3.2.2.3. By Animal Type
      • 6.3.2.2.4. By End Use
  • 6.3.3. Australia Veterinary Excipients Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Application
      • 6.3.3.2.2. By Chemical Group
      • 6.3.3.2.3. By Animal Type
      • 6.3.3.2.4. By End Use
  • 6.3.4. Japan Veterinary Excipients Market Outlook
    • 6.3.4.1. Market Size & Forecast
      • 6.3.4.1.1. By Value
    • 6.3.4.2. Market Share & Forecast
      • 6.3.4.2.1. By Application
      • 6.3.4.2.2. By Chemical Group
      • 6.3.4.2.3. By Animal Type
      • 6.3.4.2.4. By End Use
  • 6.3.5. South Korea Veterinary Excipients Market Outlook
    • 6.3.5.1. Market Size & Forecast
      • 6.3.5.1.1. By Value
    • 6.3.5.2. Market Share & Forecast
      • 6.3.5.2.1. By Application
      • 6.3.5.2.2. By Chemical Group
      • 6.3.5.2.3. By Animal Type
      • 6.3.5.2.4. By End Use

7. Europe Veterinary Excipients Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Application
  • 7.2.2. By Chemical Group
  • 7.2.3. By Animal Type
  • 7.2.4. By End Use
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Veterinary Excipients Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Application
      • 7.3.1.2.2. By Chemical Group
      • 7.3.1.2.3. By Animal Type
      • 7.3.1.2.4. By End Use
  • 7.3.2. Germany Veterinary Excipients Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Application
      • 7.3.2.2.2. By Chemical Group
      • 7.3.2.2.3. By Animal Type
      • 7.3.2.2.4. By End Use
  • 7.3.3. Spain Veterinary Excipients Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Application
      • 7.3.3.2.2. By Chemical Group
      • 7.3.3.2.3. By Animal Type
      • 7.3.3.2.4. By End Use
  • 7.3.4. Italy Veterinary Excipients Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Application
      • 7.3.4.2.2. By Chemical Group
      • 7.3.4.2.3. By Animal Type
      • 7.3.4.2.4. By End Use
  • 7.3.5. United Kingdom Veterinary Excipients Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Application
      • 7.3.5.2.2. By Chemical Group
      • 7.3.5.2.3. By Animal Type
      • 7.3.5.2.4. By End Use

8. North America Veterinary Excipients Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Application
  • 8.2.2. By Chemical Group
  • 8.2.3. By Animal Type
  • 8.2.4. By End Use
  • 8.2.5. By Country
• 8.3. North America: Country Analysis
  • 8.3.1. United States Veterinary Excipients Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Application
      • 8.3.1.2.2. By Chemical Group
      • 8.3.1.2.3. By Animal Type
      • 8.3.1.2.4. By End Use
  • 8.3.2. Mexico Veterinary Excipients Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Application
      • 8.3.2.2.2. By Chemical Group
      • 8.3.2.2.3. By Animal Type
      • 8.3.2.2.4. By End Use
  • 8.3.3. Canada Veterinary Excipients Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Application
      • 8.3.3.2.2. By Chemical Group
      • 8.3.3.2.3. By Animal Type
      • 8.3.3.2.4. By End Use

9. South America Veterinary Excipients Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Application
  • 9.2.2. By Chemical Group
  • 9.2.3. By Animal Type
  • 9.2.4. By End Use
  • 9.2.5. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Veterinary Excipients Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Application
      • 9.3.1.2.2. By Chemical Group
      • 9.3.1.2.3. By Animal Type
      • 9.3.1.2.4. By End Use
  • 9.3.2. Argentina Veterinary Excipients Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Application
      • 9.3.2.2.2. By Chemical Group
      • 9.3.2.2.3. By Animal Type
      • 9.3.2.2.4. By End Use
  • 9.3.3. Colombia Veterinary Excipients Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Application
      • 9.3.3.2.2. By Chemical Group
      • 9.3.3.2.3. By Animal Type
      • 9.3.3.2.4. By End Use

10. Middle East and Africa Veterinary Excipients Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Application
  • 10.2.2. By Chemical Group
  • 10.2.3. By Animal Type
  • 10.2.4. By End Use
  • 10.2.5. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Veterinary Excipients Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Application
      • 10.3.1.2.2. By Chemical Group
      • 10.3.1.2.3. By Animal Type
      • 10.3.1.2.4. By End Use
  • 10.3.2. Saudi Arabia Veterinary Excipients Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Application
      • 10.3.2.2.2. By Chemical Group
      • 10.3.2.2.3. By Animal Type
      • 10.3.2.2.4. By End Use
  • 10.3.3. UAE Veterinary Excipients Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Application
      • 10.3.3.2.2. By Chemical Group
      • 10.3.3.2.3. By Animal Type
      • 10.3.3.2.4. By End Use
  • 10.3.4. Egypt Veterinary Excipients Market Outlook
    • 10.3.4.1. Market Size & Forecast
      • 10.3.4.1.1. By Value
    • 10.3.4.2. Market Share & Forecast
      • 10.3.4.2.1. By Application
      • 10.3.4.2.2. By Chemical Group
      • 10.3.4.2.3. By Animal Type
      • 10.3.4.2.4. By End Use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches (If Any)
• 12.3. Mergers & Acquisitions (If Any)

13. Global Veterinary Excipients Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Product

15. Competitive Landscape

• 15.1. Croda International Plc
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. JRS PHARMA GmbH & Co. KG
• 15.3. Colorcon
• 15.4. Quality Chemicals S.L.
• 15.5. IOI Oleo GmbH
• 15.6. Lipoid GmbH
• 15.7. Gattefosse SAS
• 15.8. Azelis Group
• 15.9. Ashland Global Holdings Inc.
• 15.10. Spectrum Chemical Mfg. Corp

16. Strategic Recommendations

17. About Us & Disclaimer